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1 
INTRODUC T IOU 
"It is difficult to keep one's footing in a stam-
pede and practically impossible to think or plan 
connectedly in a panic. Therefore, the members of the 
medical profession as well as the public, who have 
been caught in the whirlwind sweep of this new med-
ical advance, have lost all sense of proportion, 
direction and balance whenever the subject of endo-
crinology is touched on. In spite of the turmoil, 
real progress can be recorded, often unheard, be-
cause of incoherent babble and ballyhoo, which is 
more vocal than constructive and conservative ad-
vances • 11 ( 33) 
In this turmoil of activity there is a growing 
sense of doubt as to the efficacy of many so-called 
hormonal preparations, and an increasing suspicion on 
the part of many that therapeutic use of certain hor-
mones may not only be without demonstrable effect in 
the course of the condition for which they are admin-
istered, but also be distinctly harmful to the patient. 
Such a state of doubt has recently arisen in re-
gard to the administration of the ovarian follicular 
hormone or of any of its derivatives, and several warn-
ings advising against promiscuous use of such estrogen-
ic principles have recently appeared editorially in 
I 
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medical journals. (23, 30). There seems to be a defin-
ite theoretical and experimental basis for the appre-
hension expressed, as it has been recognized for many 
years that during pregnancy (when physiologically there 
is increased production of estrogenic hormone) the 
growth rate of a breast cancer is increased. 
Many experiments on mice will be thoroughly dis-
cussed later which seem to show a definite carcinogen-
ic effect from estrogenic principle. 
This paper, therefore, will ~.ttempt to clarify the 
situation, to analyze the merits of the work already 
done, to point out deficiencies in the present knowledge, 
and to conclude in so far as is possible at this time,. 
whether actual danger threatens the patient treated with 
sex hormones. 
PHYSIOLOGICAL BACKGROUlID 
"The endocrine origin of breast tumors rests on 
the hypothesis that the stimuli to normal growth 
when active in increased intensity or applied over 
excessive or irregular periods of time, may result 
in atypical forms of proliferation. For that reason 
the facts of the hormone physiology of the normal 
mammary gland are of basic importance in the study 
of breast neoplasma." (70) 
It is, therefore, important to review the part 
played by estrogenic hormones in the physiology of the 
breast. There has been some discussion over the exact 
nature of this relationship, but the generally accept-
ed view as presented in most textbooks of physiology 
and endocrinology will be considered. 
Wiggers (76) in describing the development of the 
mammary glands stated: 
"The mammary glands undergo no marked changes from 
birth to adolescence. During prepubescence and pu-
berty, and correlated with the accelerated develop-
ment of the ovaries a considerable enlargement oc-
curs in the female. This consists essentially of an 
extensive development of the duct system including 
the nipples; but the glandular alveoli develop but 










that the estrogenic hormones of the ovary may be 
concerned and this has been made more certain by 
the demonstration that injections of theelin stim-
ulate proliferation in immature animals and in 
castrated males as well as females. From this 
state of pubertal development no further change 
occurs unless pregnancy supervenes." 
During the first half of pregnancy there is rather 
marked alveolar hyperplasia while during the latter half 
there is secretory awakening and hypertrophy of the al-
veoli. The evidence of many investigations has indicated 
that such preparation is due to an associated action of 
theelin and progestin (Wiggers, 76). 
According to Edgar Allen (2) the simulfaneous action 
of theelin and progestin has been found necessary to pro-
duce complete mammary growth in animals other than the 
guinea pig. 
Wiggers (76) asserted that injection of progestin 
alone does not produce proliferation of secreting epi-
thelium in spayed rabbits, but that simultaneous injec-
tion of theelin and progestin does. 
The problem, however, is not so simple as this may 
suggest. Subsequent work has shown that anterior pitu-
itary substance likewise leads to similar proliferation 
and hypertrophy. However, such an effect may be consid-
5 
ered to be either direct, by action on the breast tis-
sue itself, or indirect, by action on the ovary caus-
ing the production of theelin and progestin as it is 
known to do. 
Wiggers dealt with this phase of the problem and 
concluded that species differences undoubtedly exist. 
In the rabbit, anterior pituitary factor seems to be 
effective in the absence of ovaries, while in the guin-
ea pig and rat ovarian factors must be present. The 
effects of anterior pituitary hormone also seem to de-
pend on the preceding degree of development of the 
mammary glands; it being generally conceded that pitu-
itary factors cannot be expected to exert any action 
on wholly undeveloped glandular tissue. 
Work of investigators has generally borne out 
these statements, and in support thereof stands Edgar 
Allen (2) who st~ted in part: 
"The growth of the ma.mma.ry gland is primarily de-
pendent on the estrogenic hormones. The .Primary 
ducts of the rudimentary mammary glands of males 
have been found to respond to both theelin and 
theelol. At the present time the guinea pig is the 
only species extensively investigated in which a 
complete growth of the mammary gla.nds (both ducts 
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and alveoli) may be induced by theelin. The simul-
taneous action of theelin and progestin has been 
found necessary to p~oduce complete mammary growth 
in other animals so far studied." 
His statements were amplified further to the ef-
fect that: 
"a development of small localized lobules of alve-
oli in addition to the ducts has been observed in 
the mammary glands of male mice of an inbred strain 
following injections of theelin over a long period". 
He interpreted ~his finding to be indicative that 
localized areas of the experimentally grown mammary 
ducts may be more sensitive to stimulation with theelin. 
In the light of what is to follow this observation is 
of considerable importance. 
Turner and others (74) confirmed the finding that 
theelin and theelol are capable of stimulating the growth 
of the duct system of the mammary gland of the rabbit, 
rat and mouse, and Evans (25) in writing about recent ad-
vances in physiology summarized the work done on this 
subject in very nearly the same manner as did Wiggers. 
Thus is described the effect of endocrines on the 
breast --- so far as physiologic effects are involved. 
SUMMARY 
1) Theelin or theelol is capable of producing marked 
proliferation of the duct system in the mammary 
gland. 
7 
2) Progestin (corpus luteum hormone) alone has no ef-
fect, but coupled with theelin it produces alveolar 
hyperplasia as well as extension of the ducts. 
3) Only in the guinea pig can theelin alone produce 
the development of both ducts and alveoli, while in 
the rabbit, rat and mouse, the combined action of 
theelin and progestin is required. 
4) Allen, however, describes localized areas of alve-
olar hyperplasia in the mammary gland of the mouse 
following prolonged injections of theelin. This he 
interprets as indicative of greater sensitivity to 
theelin. 
5) Anterior pituitary hormones effect breast develop-
ment only by indirect action on the ovary (except 
in the rabbit), but the lactogenic hormone produces 
lactation in a previously developed breast. 
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STUDIES ON EXPERIMENTAL A.~IMAI.S 
Experimental attack upon the pathogenic effects of 
the female sex hormone upon the breast has followed 
essentially along three lines. 
The first of these was the finding that tar applied 
to the skin over long periods of time may induce carci-
noma. This led to the isolation of certain chemical sub-
stances from coal tar showing similar carcinogenic ef-
fect. These substances have since been synthesized. 
The second line of investigation began with the 
analysis of the mechanism underlying the sexual cycle. 
It proceeded to study the place .of origin, the function, 
and the chemical constitution of the hormones dominat-
ing in various phases of the cycle. 
The third line of investigation ~egan with a study 
of the significance of ovarian hormones in the develop-
ment of mrumnary cancer in mice. 
It was not long after the synthesis of the carcino-
genic substances present in coal tar before a chemical 
similarity was found between these substances and the 
sex hormones, and Kenna.way, Cook and Dodds (according 
to Loeb, 53) showed that certain of these chemical 
substances with carcinogenic effect were also capable 
of producing estrus in the experimental mice. 
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Further experiments to be described at greater 
length have shown that "estrogenic hormones are factors 
in the development of certain kinds of cancer". {Loeb, 
53). 
I. COAL TAR PRODUCTS AJID CANCER 
The first series of experiments began with the 
finding by Yamigawa and Ichikawa in 1915 {79) that long 
continued applications of tar to the ear skin of rabbits 
may initiate cancerous changes in the tissue thus ex-
posed to the action of this substance. 
Tsutsui {73) in 1918 extended this work by showing 
that in mice epidermal cancer can be produced in a con-
siderably larger percentage of cases than in rabbits. 
He thus established the mouse as the more favorable 
species for testing the carcino:?genic power of various 
substances related to or derived from tar. 
Chemical studies by Bloch and Dreifuss (6) next 
revealed that the compounds present in tar and respons-
ible for the production of cancer are neutral, nitrogen-
free substances possessing a high boiling point. This 
finding led to attempts to isolate the active principles 
involved. 
It has since been found that if isoprene is ex-
posed to a high temperature in an atmosphere of hydro-
gen, a mixture of compounds, chiefly aromatic in nature, 
10 
develops. This mixture was found to have marked carcino-
genic power. 
Similarly carcinogenic substances were also pro-
duced by exposing acetylene and also yeast and human 
skin to very high temperatures (Loeb, 53). 
Numerous investigators during the past decade 
have isolated pure substances from such mixtures and 
indeed many of these have been synthesized. 
Further chemical investigation has revealed a 
basic similarity in structure between the molecules of 
these various substances. It has been demonstrated that 
it is the cyclo-penteno-phenanthrene nucleus which is 
common to all these carcinogenic hydrocarbons (Evans, 
25), and that a series of compounds related to 1:2 
benza.nthracene, which itself is inactive, possesses 
especially marked carcinogenic properties (Loeb., 53). 
The statement may therefore be made, in general, that 
a molecular structure consisting of rings attached to 
the 1:2 and 5:6 positions of the anthracene ring sys-
tem tends to confer a marked carcinogenic activity. 
This series of investigations has revealed, there-
fore, that insofar as tar and the carcinogenic sub-
stances it contains are concerned in the etiology of 
cancer, the action is much more specific than had 
originally been supposed. 
Their action according to Loeb (53) seems to be 
11 
directly as growth stimulating, as they apparently may 
induce cancer formation without first causing a local 
irritation. They are not selective as regards the tis-
sue on which they act as they have been· shown to pro-
duce tumors of connective tissue origin as well as of 
epithelial cells. They effect, step by step, changes 
in the cells on which they act, eventually resulting 
in the formation of cancer from originally normal 
cells. 
chemical 
Evans (25) called attention to the closeAsimilar~ 
ity between the carcinogenic agents already described 
and cholesterol. Kennaway and Sampson (40) have ob-
tained from cholesterol heated to about 800° C. pro-
ducts which caused epithelioma of the skin in mice. 
Bourne (11) also commented on the close chemical 
similarity between the carcinogenic compounds present 
in tar and cholesterol --- even to the point of class-
ing these substances with the sterols. 
Such a structure he described also as relating 
them closely with the male sex hormone (androkynin); 
with the female sex hormones (theelin and theelol); 
with antirachitic vitamin D; and with the bile acids. 
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II. ESTROGENIC SUBSTANClf3 AND C.AlrGER 
Among the various agents described above as relat-
ed to one another chemically it is of particular inter-
est in the present discussion to study what similar-
ities and what differences may exist between the car-
cinogenic agents in tar and the estrogenic hormone. In 
other words it is now in order to study what estrogenic 
effect may be produced by the carcinogenic agents of 
tar and what if any carcinogenic effect may be ascribed 
to estrogenic hormones. 
Extensive investigations of these effects have been 
undertaken during the past twenty years. As a rule there 
has been found no relationship at all between carcino-
genic and estrogenic potency. Some of the more potent 
carcinogenic agents display weak estrogenic power. 
Others display no estrogenic power at all. In this re-
gard it is worthy of note that vitamin D is estrogenic 
while so closely related a substance as cholesterol is 
not. 
It is especially interesting to note that Cramer 
and Horning (19) applied estrin in .01% chloroform 
twice weekly to the skin of mice in the same manner 
that earlier investigators applied tar and its con-
stituent substances. In all of five males thus treated 
13 
carcinoma of the breast developed. The strain of mice 
used was one in which the females normally develop car-
cinoma mammae in large numbers, but in which the males 
never develop this type of tumor spontaneously. This 
demonstrated a specificity of estrin which is not 
possessed by the carcinogenic substances of tar ---
probably arising from the physiologic specificity of 
estrin for the breast tissue. 
Burrows (13) also reported carcinoma ma.mmae oc-
curring in two males of one hundred thirty ordinary 
mice treated twice weekiy with ketohydroxy estrin in 
benzene. He believed this significant because of the 
rarity of spontaneous mammary cancer in male mice. 
Schockaert {62) in 1935 described an ingenious 
experiment in which he treated three hundred mice 
with coal tar in the accepted fashion. To one subgroup 
he also gave dihydrofolliculin injections. ~n this sub-
group tar tumors appeared four weeks earlier than they 
did in the controls; they were more numerous (65.2% as 
compared with 27.2% in the controls at the end of five 
and one-half months); and they grew more rapidly. 
He interpret-ed_ this result on the basis of a pre-
disposing and stimulating effect produced by the fol-
liculin. His work has not as yet been corroborated, nor 
has it been contradicted. 
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Loeb concluded from his study of the facts as they 
are known and understood at present that: 
"(l) there are substances which are both carcino-
genic and estrogenic; {2) there are carcinogenic sub-
stances which are not estrogenic; (3) there are estro-
genic substances which are not carcinogenic; (4) 
even in cases in which substances are both estrogenic 
and carcinogenic, there is no parallelism between 
the strength of these two activities." (53) 
III. MAJAUARY CARCnmMA IN THE MOUSE 
The discussion turns now to a very extensive ser-
ies of experiments dealing with the significance of the 
ovarian hormones in the development of mammary cancer 
in mice. 
In 1911 Lathrop and Loeb (46) described a family 
of mice in which the hereditary transmission of a tum-
or seemed to be apparent. 
In 1914 (47) these same investigators described 
the results obtained from a series of experiments on the 
heredity of tumors in mice. This study was suggested from 
the common observation by breeders of mice that there was 
a tendency for carcinoma mammae in the mouse to occur in 
families. Their findings were, essentially, that there is 
a constant incidence of carcinoma mammae in pure strains 
of mice, the incidence varying in different strains; 
that the age of development of the tumor tends to be 
constant in each strain, but varies in different 
strains; and that both these characteristics tend to 
recur in succeeding generations. 
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In a paper written by Slye in 1920 (64) she de-
scribed the value of inbreeding of mice, not because it 
increases the incidence of cancer in mice (or in any 
other species), but because it emphasizes the hereditary 
makeup of the species or strain under study. Her work 
as well as that of many others interested in the ea.me 
field has shown that, by inbreeding, strains of mice 
may be produced some of which show a high incidence of 
mammary cancer and some a very low incidence. The im-
portant fact is, however, that she is able to predict 
not only what percent of the females will show mammary 
carcinoma in a given strain, but also at what age per-
iod these tumors will begin to appear. 
Given these basic facts as to the normal incidence 
of spontaneous breast cancer in mice the next step is 
merely to find what procedures other than altering the 
strain, will produce changes in this incidence. 
EFFECTS OF PRi~VEN'TIOU OF BREEDDTG: 
Lathrop and Loeb in 1914 (48) brought the atten-
tion of cancer research to the finding that in females 
r 
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allowed to breed freely there was a considerably higher 
incidence of mammary cancer than in mice prevented from 
breeding. They also found that in non-breeders the age 
before onset of the tumor was greater than it was in 
breeders. These facts are entirely independent of the 
difference in tumor incidence in varying strains of 
mice, although they described the finding that in rel-
atively poor breeders (where this was characteristic of 
the strain) the incidence of ma"l'll?lary carcinoma was also 
lower. The significance of this finding was recognized 
by the authors as of dubious nature. 
Bashford in a comrrunication to Lathrop and Loeb 
(48) stated that he found no influence of pregnancies 
on carcinoma in mice. 
Lathrop and Loeb in 1916 (49) described further 
experiments which corroborated their previous results. 
Maud Slye in 1920 (63) told of her experience 
with breeding females. She stated that without excep-
tion the amount of tumor grown while reproductive was 
much less than during her non-reproductive period, and 
that the amount of tumor grown by reproducing females 
was much less than that grown by non-reproducing fe-
males. 
Leo Loeb again in 1919 (51) confirmed this finding 







carcinoma of the mouse breast, but reported that breed-
ing is associated with a higher incidence of mammary 
carcinoma. Some of his data is quoted in the table 
which follows. All of the mice used were of the same 
strain. 
Mice without tumors Mice with tumors 
Non-breeders 45 1/3% 54 2/3% 
Breeders 32 2/3% 62 2/3% 
w. s. Murray in 1927 (59) confirmed Loeb's claims 
and stated that enforced non-breeding delays very 
markedly the age of tumor appearance and may inhibit 
entirely development of carcinoma in mice which would 
probably have had a high tumor incidence had they lived 
a normal sexual life. 
Cori (17) desired to check Loeb's work and found 
in 1927 that in his strain of mice, 94% of those fe-
males allowed to breed freely developed mammary cancer, 
while in non-breeding controls of the same strain only 
?8.5% developed tumors. 
Thus there seems to be ample evidence to the effect 
that prevention of breeding in female mice (1) lowers 
the incidence of spontaneous mammary carcinoma and (2) 
raises the age before development of the tumor occurs. 
During reproduction, also, there seems to be a decrease 
in the rate of growth of the tumor. 
r 
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EFFECTS OF REMOVAL OF THE OVARY: 
To further carry out the studies on the relation 
between the ovary and the breast it seemed logical to 
attempt to find out what would occur in the absence of 
the ovary. Accordingly in 1916 Lathrop and Loeb (49) 
reported upon the results obtained by castration of 
female mice. They found that castration before the age 
of six months markedly decreased the incidence of 
spontaneous mammary cancer in these mice, and that 
when a tumor did develop, it was at a later age. These 
effects were found to be greater than were the similar 
effects obtained by prevention of breeding. Castration 
after the age of six months was found to have little 
or no effect. 
The authors claimed this to be the first experi-
mental de~onstration of internal secretion as an etio-
logical factor in spontaneous development of cancer. 
They described this as a chemical factor superimposed 
on an hereditary factor distinct from itself. 
In 1919 Loeb (51) re-described the work reported 
above with a large volume o,f discussion regarding 
theoretical explanations of his findings. This will be 
taken up further in subsequent discussion. He concluded 
that: 
"In case such an influence of internal secretion 
should exist it must be a specific one. There is no 
reason to assume that removal of an organ with in-
ternal secretion should influence the development 
of cancer in organs the growth of which is not af-
fected by their internal secretion under normal 
conditions". 
Cori in 1927 (17) amplified Loeb's work by find-
ing that in as high as 15% to 18% of castrated female 
19 
mice there was a regeneration of the ovary. To elimin-
ate the effect of this he followed his castrated mice 
by the use of vaginal smears to determine absence of 
ovarian function. In none of the females castrated be-
fore the age of twenty-two days where ovarian regener-
ation failed to occur did carcinoma develop. Further-
more the castrated mice lived on the average to a 
greater age than did either the non-breeding or breed-
ing mice. Consequently in them there was a greater 
possibility for carcinoma to develop before they died. 
Murray also in 192? (59) compared the effects of 
castration and those of non-breeding. He found them to 
be very similar. He compared the age of onset of the 
tumors as follows: 
y oum:i:es t A verage Old t es 
Breeding females 4 mo. 9 mo. 14 mo. 
Non-breeding females 10 mo. 14.7 mo. 17 mo. 
Castrated females 9 mo. 15.6 mo. 18.8 mo. 
It may be concluded then that castration of the 










taneous mammary carcinoma. 
EFFECTS OF OVARIAN TRANSPLANTS IN CASTRATED MALE MICE: 
The next step in the case against theelin was the 
attempt to produce mammary carcinoma in the male mouse 
where such tumors usually are very rarely seen. This was 
carried out by the attempt to transplant ovaries from a 
female of the strain to be studied into a male, prefer-
ably a litter mate. 
Loeb (51) began this type of work in 1919. In his 
series of mice there were no mammary tumors developed. 
However, he stated that many of the ovarian transplants 
failed to grow, and that many more were apparently never 
functional. 
Murray in 1927 (59) transplanted ovaries into two 
hundred ten castrated male mice and in four of these 
tumors appeared by the age of ten to thirteen months. 
In two hundred forty-one castrated males of the same 
strain no tumors developed. 
He reported in 1928 (60) that 7.1% of these male 
mice with the ovarian transplants developed tumors at 
an average age of 14.4 months. 
Gardner (34) reported that he failed to find evi-
dence of tumors in any of his series of male mice thus 
treated, although he described the development of the 
-- ---- --------~ 
male breast to an extent comparable with that in the 
normal virgin female. 
EFFECTS OF THE I~tJECTIOU OF FOLLICULIN: 
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When Allen and Doisy in 1923 (3) isolated the act-
ive principle of the ovarian follicle they furnished 
the research workers with a new tool for investigating 
the relation of the ovary to mammary cancer. The in-
vestigations using ovarian follicular hormone are many, 
and only a few of the more important ones can be touch-
ed upon in the ensuing paragraphs. 
Cori (17) as early as 1927 attempted to produce 
mammary tumors by injection of follicular hormone, but 
found that none were obtained. He felt that this was 
due to the fact that an oily preparation of the hormone 
was used and because of reactions to this the treatment 
could not be carried out over a sufficiently long period. 
Lacassagne (42) obtained the first positive results 
in 1934 when he noted that in one family of mice treat-
ed by injections of folliculin there was more abundant 
and more precocious breast development than in another 
similarly treated. He found also that the former had a 
greater tendency toward the development of spontaneous 
mammary cancer than did the latter. There was also an 
apparent relationship between the estrus cycle and the 
cancer rate. This finding is part of another phase of 





Harde (38) confirmed I,acassagne' s work with some-
what less definite results. He also remarked that in 
mice belonging to strains displaying low tumor rates, 
the glands functioned less and the mothers nursed their 
young for a shorter time than did those mice belonging 
to high tumor rate strains where lactation was also 
greater. This interesting point brought out by Harde 
has not since been confirmed nor has it been discussed 
except in relation to the human. 
Both Lacassagne and Harde remarked an exaggaration 
of e.strus in mice during the precancerous state. 
Lacassagne in 1936 (43) reported that in twelve 
males given weekly injections of folliculin from the 
time of birth, eleven developed adenocarcinoma of the 
breast. This he believed significant since males rarely 
develop this tumor. Seven of nine sisters of these males, 
all of whom were similarly treated, developed tumors 
pathologically indistinguishable from those in the males. 
In another strain where less than 2% of the females de-
velop spontaneous mammary carcinoma five of six males and 
all of four females ~iven similar injections developed 
mammary carcinoma. His series is quite small, but may 
be significant in view of the nearly 100% results. 
Burrows (13) reported in 1936 because of the rarity 






opment of such tumors in two males of one hundred thirty 
ordinary mice. These mice had been subjected to the ap-
plication to the skin of a benzene solution of theelin. 
Bonser reported in 1935 (9) and again in 1936 (10) 
that she had been studying the effect of weekly injec-
tions of ketohydroxyoestrin benzoate in two strains of 
mice. The males only were used. In three of nineteen 
males of a strain whose females show a high tumo_r rate, 
tumors developed. In none of thirty-four males of a 
strain of low tumor rate did tumors appear. 
Suntzeff and co-workers in 1936 (68) stated that 
males are as prone as females to develop carcinoma of 
the breast if they are injected with large enough doses 
of estrin. 
Cramer and Horning (19) reported that tumors ap-
peared in all of five males subjected to application of 
oestrin in chloroform to the skin. This confirmed Bur-
rows work. 
Gardner and others {35) reported carcinoma in two 
of six males under weekly injections of keto-estrin 
benzoate. 
MacDonald (56) in studying the effects of estrin 
and progestin in rabbits failed to find any evidence 
suggestive of a production of specific pathologic lesions 






Loeb (46, 47) early conceived the idea from his 
work that carcinoma of the breast was at least in part 
an hereditary condition. This conclusion was drawn from 
data which has already been described. He felt also 
that the hereditary factor was only a part of the etiol-
ogy. He believed from his studies on the effects of 
non-breeding and of breeding in mice that there must be 
in addition to the hereditary predisposition an intern-
al, intrinsic, or endogenous factor which affected the 
mammary gland. This he firmly believed to be the ovary. 
His idea was that in order for a carcinoma to develop 
in the breast there must be, first, an hereditary pre-
disposition, and, second, an ovarian factor. This 
theory, of course, obviously explains the absence of 
such tumors in the males since only the hereditary 
factor was present in them. It also explains the vary-
ing tumor rates in pure strains, as he claimed that the 
tumor rate is either the product or the sum of the two 
factors. 
He later altered his conception somewhat (51) to 
include as a third factor that of irritation, but he 
still held to the idea that neither the ovarian factor 
nor the hereditary factor alone can produce carcinoma. 
The absence of tumors in the male breast might result 
------------
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from one of these things: {l) structural differences 
between the male and female breast; {2) absence of ef-
fect of pregnancy and/or nursing in the male; (3) ab-
sence of direct influence of the ovarian hormone. Of 
the three, he felt that the third is the more likely. 
In 1924 the conception arose that the hereditary 
factor in ma"lll'Ilary carcinoma might be identical with 
some inherited differences in the estrus cycle. Loeb 
adhered to his previous belief in two separate and dis-
tinct factors (52),but it remained until 192? before he 
and Genther (54) studied and charted the estrus cycles 
of many mice of different strains. They found wide 
variations in the characteristics of the cycle in mice 
of the same strain as well as in those of other strains, 
and concluded that in all probability there is no defin-
ite· relation between length of the sexual cycle (the 
ovarian factor) and the hereditary tendency to carcinoma. 
They added that work must, in the future, look further 
than the ovary to find the basis of heredity in cancer. 
Bonser (8) in 1935 after similar studies concluded 
that there was no connection between the estrus cycle 
and what she designated as "a genetic factor" which "in-
hfbi ts" tumor development. This is really a confirmation 
of Loeb's belief stated in a different manner. 
Moskop, Burns, Suntzeff, and Loeb (58) in 1935 con-
------------
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firmed again the absence of correlation between the es-
trus cycle and heredity in mammary carcinoma. The same 
authors reported the same results again in 1936 (12, 
67). 
The only dissenting opinion is that of Lacassagne 
~2), who in 1934 claimed that he was able to demonstrate 
a relationship between breast development, cancer rates, 
and the estrus cycle. His work would indicate that pre-
cocious breast development and a high cancer rate were 
associated with a definite type of estrus cycle. This 
has not as yet been confirmed. 
Cori (17) agreed with Loeb's point of view but add-
ed that the organ predisposition to cancer remains la-
tent in the absence of ovarian function but becomes man-
ifest when an amount of ovarian hormone corresponding to 
five to thirty estrus cycles has acted on the breast tis-
sue~ He felt, therefore, that the ovarian factor was real-
ly dual in nature·-- first, i~ produced development of 
the breast, and, second, it provided a periodic etimula.-
tion of the breast tissue. 
Murray (59, 60) suggested in 1927 and 1928 that 
one possibility might be that the cessation of ovarian 
activity after a period of activity was the chief fact-
or in producing mammary cancer. Such a condition is 
found in female mice castrated later in life, and in 
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their case tumors developed more frequently tha.n they 
did in non-breeding females, where there was no cessa-
tion of ovarian activity. The accompanying table il-
lustrates this fact. 
:Hum'Der used % tumors usual rate 
Non-breeding females 207 11.5% 80% 
Castrated females 210 17 .ljb 80% 
Gardner (34) disagreed with Loeb and Cori. He 
felt that the ovary was responsible for mammary carci-
noma only in so far as it developed the breast and 
therby furnished a site in which the carcinoma might 
develop. His contention was based on the finding that 
in males treated either by ovarian transplants or by 
estrin injections a duct system comparable to that in 
normal virgin females developed. He was unable to ob-
tain tumors in any mice so treated, although all but 
three were from susceptible strains. 
If it be assumed, then, with Loeb, that for a 
cancer to develop in the breast two factors at least 
are essential -- namely, an inherited organ predispos-
ition and an ovarian factor -- the second of these 
factors should be considered as to the mechanism 
underlying its action. This has already been briefly 
touched upon, but now the discussion turns to a more 
careful consideration of this point. 
Several mechanisms may be presupposed. 
(1) According to Gardner (34) the ovarian hor-
mone is a factor only in so far as it develops the 
breast. 
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(2) According to Allen (2) certain localized 
areas of mammary ducts may be more sensitive than 
others to sti~ulation with theelin. This was suggested 
by a finding already mentioned in the discussion of 
physiology. 
(3) According to Lacassagne (44) carcinoma is most 
com.man in ducts commonly plugged (breast, sebaceous 
glands, sudorific glands, uterine glands, and the pros-
tate) and the retained secretion may contain enough 
stagnant estrin to act as a carcinogenic agent. In 
favor of this view he called attention to the fact that 
colostrum is high in estrin content, and tha~ in the 
human, carcinoma frequently arises out of cystic disease 
of the breast. 
Further evidence of this effect was given by Bogen 
(7) in 1935. By removal of young from the mother mice at 
birth there was a tendency for carcinoma to appear in 
those breasts which were not suckled. Similar results 
were obtained by ligating one nipple and permitting the 





Suntzeff, Burns, Moskop, and Loeb (68) could demon-
strate no effect on tumor production following ligation 
of the ducts, but the experiment was apparently not well 
controlled as secretions of the untouched breast were 
not removed by suckling. 
Fekete and Green (27) performed a similar experi-
ment save tha.t they cauterized one nipple with a hot 
wire in place of ligating it. In a high tumor strain of 
mice they found that 557~ of tumors which appeared follow-
ing this procedure were in the breast whose nipple was 
obliterated. In a low tumor rate strain no tumors appear-
ed in that breast. 
A personal communication from Dr. J. H. Schmela re-
garding the incidence of carcinoma of the mammary gland 
in cattle is interesting. In his entire experience of 
twenty-five years as a veterinarian he has seen but two 
or three cases. The milk ducts of the dairy cow are cer-
tainly not allowed to become stagnated. 
(4) According to Burrows (14) the effects of estro-
gens are limited entirely to organs belonging to or 
representative of embryologic remnants of the reproduct-
ive system. This indicates a specificity of theelin not 
possessed by ot~er carcinogenic substances. Other authors 





Horning, 19). Burrows in addition described the response 
to theelin obtained from such organs. Their epithelium 
undergoes apparently the following changes:~) arrest 
of function, (B) hyperplasia, (C) metaplasia,and ulti-
mate keratinization, and (D) suppuration. 
Cramer and Horning (19) described the hyperplasia 
which occurs and labeled it the "precancerous condition". 
All the theories so far advanced admit that the 
ovarian hormone is concerned in the development of carci-
noma of the mammary gland of the mouse. The exact manner 
in which this takes place is still a matter for specula-
tion and further investigation and cannot be determined 











MAMMARY CARC r.~:ro:M'A IN THE HOJ.!AN 
EFFECTS OF BR..~EDING Atill LACTATION GN TU1!0R INCIDENCE: 
As long ago as 1845 Sir Astley Cooper (16) said: 
"Suckling ••• diminishes the disposition to mal-
ignant diseases of the breast, for although women 
who have had children are still liable to cancer-
ous and fungoid diseases, yet it is undoubtedly 
true, that breasts which have been unemployed in 
suckling, in women who have been married, but are 
childless, and in those who have remained single, 
are more prone to malignant diseases than those of 
women who have nursed large families If • • • 
Lane-Claypon (45) reported in 1926 a statistical 
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study which was very elaborately worked out. This was a 
survey of cases in Glasgow and London hospitals. She 
stated: 
''the married state and the production of children 
far from being conditions favourable to the occur-
rence of cancer of the breast, are substantially an-
tagonistic to it. • • • Lactation, even when repeated 
in successive pregnancies, does not appear, per se, 
to be a circumstance which has influence, one way or 
the other, on liability to cancer •••• The breast 
which has never been called upon for normal function 








In her studies the women were divided into a can-
cer series and a control or non-cancer series. She found 
that in her control series as compared with her cancer 
series there were on the average (1) an earlier marriage, 
(2) an earlier climacteric, (3) a longer mean duration 
of marriage before the climacteric, and (4) more children 
and fewer miscarriages and stillbirths. The following 
chart displays these findings. 
CANCER SERIES 263~ COUTROL SERIES 2S5 ~ 
Means Standard Dev. Means Standard Dev. 
e at marriage 










She found that those women who ultimately developed 
carcinoma bore 22% fewer children than the controls (allow-
ing properly for the relative duration of marriage). This 
finding would indicate that fertility and low incidence of 
breast cancer are related. 
She concluded also that any connection between cancer 
of the breast and lactation lies in the absence of func-
tion or in the excessive use of the breast. Unilateral 
lactation does not appear to have any untoward influence 
in causing cancer of the breast so used. 
Von Winiwarter (??) in an extensive statistical 
study in 1878 concluded that the more seldom a woman gave 
birth to children the greater were her chances of develop-




While the studies described above were made from 
individual case records and therefore reflect an accurate 
picture of the cases studied, another method of analyzing 
large groups of cancer cases was undertaken in 1935 by 
Emil Bogen. 
He (7) found from his studies of vital statistics 
that in those st~tes with low birth rate (from females 
aged between fifteen and forty-four years at the time 
of their delivery) in the year 1900 there was a higher 
incidence of deaths from mammary cancer in 1930, among 
women over forty-five. The statistics were taken at 
this thirty year period to permit women in the child-
bearing ;,ears in 1900 to reach the cancer age in 1930. 
The inverse ratio he described above he found nearly 
consistent for all the states, and upon this fact he 
based his contention that breast cancer is more common 
in those states where the birth rate is low. 
A study of vital statistics from countries other 
than the United States was made. This revealed a strik-
ingly similar inverse ratio -- with England and Scot-
land high in death rates from breast cancer and very 
low in birth rate. Japan and Chile footed his list with 
low breast cancer death rates and high birth rates. How-
ever, in studying the material presented by Bogen too 
much reliance must not be placed upon data reported by 
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countries where registration of births and deaths is 
not well kept. Another fault lies in the fact that the 
average age at death is not constant in different coun-
tries and the possibility therefore exists that in some 
places the women develop cancer because they live longer. 
However, his study is well worked out and is 
interesting from the speculative standpoint. Inasmuch as 
it supports previous studies it may be of value. 
Thus, it has been found that comparative infertil-
ity or sterility is associated with a high incidence of 
breast cancer, and that among those women who have borne 
and nursed children the cancer rate is considerably low-
er. 
EFFECTS O:B' BREEDING AND LACTATIOU 01~ TU1..!0R GROWTH: 
It is important to distinguish between the effects 
of pregnancy and lactation on a tumor not yet present 
and on one already present and growing. 
Trout (72) in 1922 described two cases of women, 
aged thirty-two and thirty-four years, each of whom had 
had amputation of one breast for carcinoma and both of 
whom subsequently became pregnant. About the sixth month 
tumors appeared in their remaining breast and grew un-
usually rapidly. 
He reported also receiving letters from sixty-two 
surgeons. Of these, forty-six volunteered the informa-
l 
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tion that they had "noticed that pregnancy apparently 
stimulated cancer to develop more rapidly no matter 
where the growth might be located." In this series of 
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replies were reported seventeen cases of breast cancer 
associated with pregnancy. All of these were seen late 
in the disease, and all went to a rapid and fatal term-
ination. He also found in this series that there had 
been fifteen instances when pregnancy occurred after re-
moval of one breast. Of these, thirteen (nearly 89%) 
developed carcinoma in the remaining breast and twelve 
died very promptly. 
In 1934 Farati (26) described six cases of breast 
carcinoma in his clinic which were coincident with preg-
nancy or with lactation. He did not present details of 
these cases, but he concluded from his experience that 
the malignancy of breast cancer is markedly increased by 
either of these conditions. 
In 1936 Schockaert (62) reported the cases of two 
females with mammary carcinoma who became pregnant. In 
both, the neoplasms grew unusually rapidly. 
The frequency of carcinoma occurring in the second 
breast after amputation of the first has been investi-
gated by Kilgore (41). In 1921 he stated that: 
"the patient who has had one breast amputated for 






four times more likely to develop cancer in the sec-
ond breast than a normal woman of the same age in 
either of her two breasts." 
His description also told that he felt that the tum-
or appeared to be primary in each breast although in some 
cases it might have been metastatic. This he felt suggest-
ed a "cancer diathesis". 
Emge (24) reviewed the literature pertaining to the 
effects of pregnancy on tumor growth. He found that an 
inhibitory effect on tumors in general was commonly de-
scribed. However, he concluded that neoplastic tissue 
sensitive to hormonal stimuli may exhibit increased 
activity during pregnancy. He reported one case of breast 
carcinoma which:1had been previously treated by breast 
amputation and by X-ray. This patient developed a recur-
rence during a pregnancy. There was rapid metastasis, 
premature delivery, and death by the sixth month from a 
generalized carcinomatosis. 
With this evidence it may be concluded then that in 
women who become pregnant after having had one breast re-
moved for cancer, there is grave danger of it appearing 
in the other breast. This may be due to the fact that 
pregnancy seems to stimulate the growth of breast malig-
nancies, and this effect may well be expected from the 
normal physiological stimulation of the breast during 
pregnancy. 
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EFF.l:;;CTS OF OVARIECTOMY: 
It is, of course, impossible to use ovariectomy in 
the human as an experimental means of studying cancer of 
the breast. However, in 1896, Beatson (5), an English 
surgeon, suggested on the basis of some observations 
which he had made that o~phorectomy might possibly be of 
benefit in treating a cancer of the breast. He used this 
method in two cases and reported the patients "cured". 
Alexis Thomson (71) followed Beatson's ideas and 
analyzed eighty cases in which there had been used this 
sort of therapy. He found eighteen cases in which there 
was decided improvement and some regression of the tumors. 
Eleven cases showed less improvement, and fifty-one showed 
no appreciable change in the course of the disease. 
CARC DIOMA OJ!, THE MALE BREAST: 
It has been generally conceded that carcinoma of the 
male breast is a rare occurrence. Just how rare it is is 
shown by reference to the Mortality Statistics for the 
United States (75). Below is listed the number of deaths 
from cancer of the breast for several years' time. 
MAI.E FEMALE -
YEAR White Negro White }.Tegro 
1934 150 11 12,220 768 
1933 145 21 11,516 766 








Obviously there is a marked difference in the 
incidence of this disease between the two sexes. Just 
what is the reason for this? 
Of course the suggestion at once occurs to the 
investigator that the reason is the lack of breast de-
velopment in the male. This, however, must remain 
speculative, as experimental studies on the human being 
are seldom permitted. 
However, occasionally a male breast does develop. 
This condition is referred to as gynecor.iastia. The occur-
rence of this in itself is rare. \'/hen it does appear it 
is usually unilateral. 
According to Geschickter, Lewis and Hartman (36) 
gynecomastia occurs most frequently in males of the 
white race between the ages of thirty and forty years. 
These men stated that the lesion is more frequently uni-
lateral than bilateral, and in their series it occurred 
about just as frequently as ·carcinoma of the male 
breast. However in no case of gynecoTiastia did they find 
evidence of malignancy at any time. 
Cheat le and Cut le~ ( 15) ata.ted that the development 
of carcinoma in a breast which is the seat of gynecomastia 
has been recorded, but it is so rare that the event may 






Thus although an occasional male breast does reach 
a "virginal" stage of development (so described by Ge-
schickter, 36) the incidence of cancer in such breasts 
is low enough to eliminate the suspicion that the cause 
of the gynecomastia and the cause of the carcinoma of 
the breast are identical. 
ESTROGE:N"IC HORJJO}ffi r~r THE FEMALE: 
The following discussion deals with the occurrence 
of the estrogenic hormone in the human female. 
Allen and Daisy (3) in a preliminary report on an 
ovarian hormone in 1923 described the isolation and par-
tial purification of the ovarian follicular hormone. 
Therebyarose the search for its presence in other organs 
in the body and for its presence in excreta and secreta. 
Before their discovery, Stockard and Papanicolaou 
(66) in 1927 described changes in the vaginal fluid of 
the guinea pig during various phases of its estrus eye-
le. Although they failed at the time to realize the value 
of this finding from the standpoint of its later use as 
a test for follicular hormone, such became the case. At 
present when follicular hormone is being tested for, 
virgin castrated female animals are used and the prepara-
tion being examined is injected. The vaginal fluid then 
reveals whether the fluid injected contained theelin or 





















from the vaginal smear and produces a desquamation of 
keratinized cells in their place. Utilizing this method 
many interesting findings have been uncovered. 
In 1930 Dingemanse, Freud, de Jongh, and Laqueur 
(20) were struck by their finding that in twenty-nine 
persons, all of whom had a carcinoma, very high quan-
tities (up to 10,000 M. U. per liter) of menformon 
(follicular hormone) were found in the blood. They gave 
no details of the cases and drew no conclusions. 
In 1932 Loewe, Raudenbusch, and Voss (55) told of 
Dingemanse's work and stated that Zondek in 1931 was un-
able to confirm this. They analyzed non-genital carci-
nomata of males and found 125 ld. U. of female sex hor-
mone per kilogram of tissue. 
Frank (28) in 1934 described the normal content of 
female sex hormone in the blood. His figure was 1 M. U. 
per twenty cubic centimeters of blood. This he said is 
the maximum normal amount. In the urine there may be as 
high as 10,600 units per liter {as in pregnancy or dur-
ing ovarian hyperfunction). He stated that he had found 
by this method that even after the menopause cyclical 
ovarian activity may continue for years. This is, of 
course, slightly diminished. In some cases it is, how-




He further described the normal findings in the 
blood and urine in 1934 (33) and in 1935 (29). The sex 
endocrine principles have been demonstrated in the pla-
centa, in bile, sweat, saliva, and in cerebrospinal 
fluid. The estrogenic principle circulates each month in 
ever increasing concentration until the onset of men-
struation when there is a marked drop. There is with 
this increasing secretion an increasing curve of urinary 
excretion. 
During pregnancy a higher level of the estrogenic 
factor is noted in the blood after the eighth week, and 
there is a dis-pro-portionately greater increase in the 
quantities excreted in the urine. 
After the menopause for as long as two years he has 
been able to demonstrate estrogenic factor both in the 
blood and in the urine. 
Frank, Goldberger, Salmon, and Friedman (32) de-
scribed the finding of large amounts of estrogenic factor 
varying from 800 to 8000 l.{. U. per kilogram in the psoas 
muscle of four normal cyclical females. On the basis of 
this finding they warned against basing conclusions on 
the mere presence of estrogenic factor in abnormal tis-
sues unless it should later be shown {which as yet has 
not been done) that estrogenic factor is not widely 
distributed throughout the body of the human female. 
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In 1936 Frank, Goldberger, and Salmon (31) told 
of finding that the estrogenic factor continues to be 
excreted after surgical removal of the ovaries as well 
as after the physiological menopause. The same is 
found true after X-ray C8.stration. ~.Jo satisfactory ex-
planation of the source of this estrogenic principle 






In turning to a consideration of t~e relationship 
of breast cancer and theelin certain facts must be cor-
related. These are listed as briefly as possible in the 
following table. 
PROCEDURE EXPERlK~~TAL ANIWi.AL IiUMAN 
Breeding & Increases tumor incidence Decreases 
Lactation Lowers tumor age incidence 
Pregnancy Decreases tumor growth Speeds 
growth 
Ovariectom.y Decreases tumor incidence promotes 
Raises tumor age involution 
Radiation Decreases tumor incidence :promotes 
castration involution 
Injection of Produces CA in male or f e- Dangerous? 
folliculin male of susceptible strains 
Incidence in Very rare 1 in about 
males 100 cases 
Any satisfactory explanation must, therefore, take 
into consideration the diametrically opposed findings 
in regard to the effects of breeding and lactation. This 
finding alone is so difficult to explain that it is suf-
ficient cause for giving up any attempt at explanation 
on the basis of our present knowledge. 
But this is not the only obstacle present. Other 
points which require explanation are: the rarity with 
which carcinoma appears in a male breast which is the 
seat of gynecomastia; the fact that in a considerable 




after the menopause; the fact that the bearing of child-
ren seems to exert a prophylactic effect against the 
development of cancer of the breast. 
Certainly no one theory so far advanced can explain 
satisfactorily all these points. There have been already 
presented in connection with the discussion regarding 
tumor incidence in mice several theories. 
The first of these considered the ovarian hormone 
a factor only in so far as it developed the breast. This 
is of course inconsistent with the observations in gyne-
comastia. 
The second suggested that certain portions of breast 
tissue might be more susceptible than others to stimula-
tion with theelin. This of course offers an explanation 
only for the pathogenesis. 
The third of these was suggested by the !requency 
with which cancer occurs in glands whose ducts commonly 
become plugged. This stagnation theory has been taken up 
by several -- even in the pseudo-scientific manner of 
the lay press (Walter Martin in Coronet, 57). Lacassagne 
(44) hinted that estrin secreted into the ducts thus 
blocked might be the causative factor. He called atten-
tion in support of this suggestion to the high estrin 
content in colostrum. Others claimed other agents as the 
carcinogenic one. Bogen (7) suggested that reduced 
r· . ~·-----· 
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derivatives of cholesterol (which were shown to be car-
cinogenic by Kennaway and Sampson, 40) formed in the stag-
nant secretions could be responsible. It is well known 
that milk contains a considerable quantity of cholesterol 
(Ansbacher and Supplee, 4). Lacassagne further called 
attention to the frequency with which cancer arises out 
of cystic disease of the breast. Geoffrey Bourne (11) 
called attention to the fact that there is a close 
relationship between the cancer age (which he designates 
as forty to sixty years) and the alteration in the ster-
ol metabolism (evidP-nced by arteriosclerosis and other 
changes). He concluded, provisionally, that cancer re-
search in the future will depend on research among the 
sterols. 
The specificity of the carcinogenic power of theelin 
hHs been alluded to by many. This property should be ex-
pected from its physiological action upon the tissues re-
lated to the genital system. 
Ahlborn (1) modified Wintz's views to sa.y that even 
though theelin may have no direct carcinogenic effect, 
certainly its action in producing a periodic hyperemia 
and activity in the breasts during pregnancy and lactation 
and during the monthly cycle must be considered, at the 
very least, predisposing to the appearance of a cancer or 





In 1889 Schinzinger (61) propounded a theory upon 
which he hoped to base a treatment for carcinoma of the 
breast. This theory was developed following observations 
upon women who had for various reasons had bilateral 
oBphorectomies. He noted the cessation of the menses, 
the withering B.nd atrophy of the breasts. He knew the 
greater malignancy of carcinoma of the breast which de-
velops during the child-bearing era. Thus has idea was 
to make the woman "old" while she was still young -- in 
other words remove her ovaries and precipitate an un-
usually early climacteric. 
This plan of his he redescribed in 1905 (61) nine 
years after the British surgeon Beatson had suggested a 
similar idea. At that time he reported four cases in 
women between the ages of thirty and forty. In these 
cases there was rapid metastasis, recurrence, ulcera-
tion, and death despite a mammectomy. In several others 
past the menopause life was prolonged for many years 
after the mammectomy. He reported, however, no results 
from treatment following his plan. 
Beatson in 1896 (5) suggested independently that 
women suffering from carcinoma of the breast be subject-
ed to extirpation of their ovaries. His reasoning was 
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based on a different belief, however, as he felt that 
carcinoma of the breast was partly dependent upon an 
abnormal ovarian function. He reported two cases treat-
ed by castration as cured. They were undoubtedly at 
least alleviated. 
In 1902 (5a) he described the indications for oe-
phorectomy as requiring that the woma.n be still menstru-
a,ting and that she have an absence of metastases in the 
viscera or bones. 
He felt also that the thyroid had an action on the 
breast which antagonized that of the ovary. Consequently 
he also used thyroid gland extract ten grains, twice 
daily, in addition to the oephorectomy and the local 
treatment of the breast by amputation.No other invest-
igators lB.ve confirmed his belief in thyroid, nor has it 
been used in this way since. 
Alexis Thomson (71) was one of those to follow 
Beatson's lead. In 1902 he reported an analysis of cases 
treated by ma.m,~ectomy and oBphorectomy. In eighteen there 
was decided improvement, and life was prolonged for more 
than twelve months. In eleven cases there was decided im-
provement but life was not prolonged for twelve months. 
There were fifty-one cases with no appreciable change in 
the course of the disease. He concluded from his study· 
that the beneficial results following oephorectomy are 
sufficiently established to eliminate any question of 
r I'"' -' I 
coincidence or of error in diagnosis. He revised the 
indications for the procedure to say that (1) it is 
not contraindicated by the previous occurrence of the 
physiological menopause; (2) it is contraindicated by 
the presence of metastases in viscera or bones. 
Lett (50) in 1905 reported an analysis of ninty-
nine cases of carcinoma of the breast treated by o~-
phorectomy in addition to local treatment. Of these, 
23.2% showed very marked improvement; there was dis-
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tinct improvement in thirteen others. If he omitted all 
cases over fifty years of age, seventy-five remained, 
and of these 29.3% showed very marked improvement; 
there was found distinct improvement in nine others. 
He obtained no "cures" with one possible exception. 
He noted that the improved condition lasted for a 
period which varied from one to five years. 
Following these observations removal of the ovaries 
in breast carcinoma enjoyed a vogue for quite a period 
of time, but with the advent of X-ray and the discovery 
that it could be used to produce an artificial menopause 
and thereby obviate the dangers of a major operation, 
the popularity of surgical castration began to wane. 
Foveau de Courmelles was apparently the first to 
use X-ray in castration for carcinoma of the breast. He 




time reported results. In 1926 (18) he discussed the ques-
tion of dosage of X-ray necessa.ry to produce cessation of 
ovarian function, and told that it v.-•ried with individual 
cases and that he himself varied it tentatively. He de-
scribed none of the results obtained, but his technique 
included X-rRy of the breasts and metastases as well as to 
the ovaries, and so the results were not well controlled. 
Hugo Ahlborn (1) in 1930 described a series of one-
hundred sixty-three cases treated in three different ways. 
Some received X-ray only to the ovaries, some to both the 
tumor, metastases, and the ovaries, and some only to the 
tumor and its metastases. From this controlled series he 
was unable to obtain statistical evidence of beneficial 
effect from the use of ovarian irradiation, unless he 
eliminated from his series all those women who were more 
or less debilitated before treatment was given. 
As dosage, he used the following factors: a sup~r­
ficial dose of 2/3 to 1 SED at focal distance 30 to 40 
cm. with a filter consisting of .5 mm. of copper and 1 mm. 
of aluminium. This was given over two anterior fields each 
12 x 12 ems. and one common back field 20 x 20 ems. The 
treatment was given in the course of three days. Current 
used was 6 mA., and the voltage was 160 kilovolts. By this 
means an active dose at least 40~ SED was delivered to 
e8ch ovary. 
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In 1933 Hoffman (39) reported a case in which there 
had been metastases in the scalp, chest and pelvis. By 
the use of heavy doses of X-ray to the pelvis (primarily 
directed at metastases there) he found that following 
the cessation of the menses the scalp metastases dis-
appeared. The patient improved considerably and gained 
in weight and strength following this castration. Meta-
stases present in the liver, however, apparently pro-
gressed. 
The dosage he used he described as follows: 200 
kilovolts, 4 mA., 50 cm. target-skin distance, given 
over four portals, 800 r units to each field. The time 
he gave as 75 minutes. 
Taylor (69) discussed the general topic of "Arti-
ficial Menopause in Carcinoma of the Breast''. He summar-
ized in very good fashion the present day beliefs in 
regard to this subject very much as follows: 
0 Patients with inoperable and recurrent carcinoma 
of the breast may be benefitted by radiation castra-
tion. Younger patients may be expected to respond 
rnor8 favourably. 
"Radiation castration following radical operation 
may inhibit or postpone the development of metastases. 
"Subsequent pregnancy involves a grave hazard of 
recurrence 
activatingl\of of stimulg,ting development of primary 
r ·r~ 
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carcinoma of the second breast and should not be per-
mitted. In the cases who refuse radiation castration, 
simple mastectomy of the remaining breast should be 
considered. 
"The treatment of operable carcinoma of the breast 
complicRted by pregnancy should include prompt abor-
tion. 11 
With this last statement McGoogan is in almost com-
plete accord. In a. consideration of bone tumors compli-
cateiiby pregnancy, (al) ,yet unpublished, he will state that 
abortion is indicated in carcinoma of the breast where 
there are no bone metastases. He believes that abortion 
is of no value in saving the mother in such an event. 
Witherspoon (78) in 1936 advanced the hypothesis 
that in patients with carcinoma of the breast whether it 
be primary or secondary, operable or inoperable, recur-
rent or metastatic, all ovarian activity should be de-
stroyed by means of high voltage radiation by Roentgen 
ray. 
Dresser (22) described his feelings in the matter, 
pointing out that carcinoma of the breast in a young 
woman is usually more malignant than in women who have 
passed the menopause; that it runs a more rapid course 
and ands fatally in a large percentage of cases regard-
less of all known therapeutic measures. He emphasized 
the fact that pregnancy may cause an exacerbation of 
malignancy of the breast with an unusually rapid pro-
gress of the disease. He stated that an operable car-
cinoma is rarely observed late in pregnancy. 
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He reported a series of thirty pre-menopausal 
women with carcinoma treated by means of ovarian ir-
radiation with remission of symptoms and regression of 
metastases in 30%. 
On the basis of this he recommended routine exam-
ination of bones, lungs, etc. for metastases. If they 
are found absent he advised the procedure be radical 
mastectomy followed by ovarian irradiation if the woman 
is not past the menopause. If metastases are present he 
advised radiation to the breast, to the metastases, and 
to the ovaries. 
Trout (72) in 1922 confirmed a belief that sur-
geons should warn their patients who are in the child-
bearing era and from whom a carcinoma of the breast has 
been removed, not to become pregnant for fear of serious 
trouble in the remaining breast. 
Schockaert (62) sounded a similar warning note, add-
ing that a woman suffering from or cured of carcinoma or 
any pre-cancerous lesion should never be given theelin 
for therapeutic purposes. 




castration as follows: (1) disappearance of pain, (2) 
return to good health, (3) recalcification of bony 
lesions, (4) no relief from further or local radiation 
after recurrence, and (5) rapid death after recurrence-
He emphasized the value of X-ray castration in re-
lieving the patient's symptoms for a variable time, and 
the rapid death of the patient which follows upon re-
currence, he considered highly desirable as it relieved 
the prolonged bed-ridden stage of the untreated disease 
which causes so much grief to the patient, her family, 
and her doctor. 
He reiterated the warning that further pregnancies 
should be avoided and that any woman under fifty who de-
velops carcinoma. should be immediately sterilized by the 
use of X-ray. 
Dr. H. B. Hunt in a personal communication discussed 
the value of X-ray castration of the female suffering 
from breast cancer as a palliative means. He told of re-
lief from pain and other distressing symptoms which is 
quite spectacular, following this treatment. He has had 
experience with it personally at the University Hospital 
and at Mebraska Methodist Hospital. The use of X-ray, 
however, is not limited to the ovaries in his technique, 
but is directed also against the metastases and the pri-
mary tumor if surgery has not been used. He told of a 
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feeling that irradiation castration has a definite place 
in the therapy of breast cancer. 
He reported a personal communication from Dr. c. C. 
Little who has been working with irradiation castration 
of mice. He found that such treatment of females of 
strains with a high incidence of spontaneous mammary 
carcinoma markedly lowered this incidence. His work is 
as yet unpublished. 
The therapeutic use of theelin in various gynecol-
ogic disorders has been frowned upon by editorials ap-
pearing in medical journals (23, 30). For that reason 
a discussion follows as to the dangers, if a.ny, attend-
ant upon its use. 
Schockaert (62) in 1935 emphatically declared that 
theelin should never be given to a woman suffering from 
or cured of cancer or any pre-cancerous lesion. This of 
course on the basis of our present feeling in the matter 
does constitute a definite contraindication to the use 
of theelin. 
E. c. Dodds (21) in 1935 was skeptical of the carci-
nogenic power ascribed to theelin. He felt that "an ex-
tensive search of the literature fails to reveal any in-
controvertible evidence that the estrus-producing hor-
mone is carcinogenic". 
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Hans Guggisberg (37) stated that while· there is 
some evidence to show that some of the hormones under-
lie the development of certain kinds of tumors, the 
surface of this field has hardly yet been scratched. 
Cramer and Horning (19) felt that theelin does 
exert a carcinogenic effect, but they called atten-
tion to the fact that ir. mice intensive therapy must 
be e;i ven for a long time in order to p:-oduce care inoma. 
This period constitutes seven to ten years of a human 
life. :-re concluded that since no such active therapy as 
this is used in the human no alarm need be felt. 
Nevertheless editorial comment warns aga.inst the 
use of large doses of estrogenic substances until fur-
ther study establishes definitely their role. Estrin 
therapy should be withheld in patients with definite or 
possible susceptibility to tumors (23). 
Frank, speaking editorially in the American Journal 
of Obstetrics and Gynecology (30) stated that the evidence 
of the estrogenic properties possessed by carcinogenic 
agents and the close resemblance chemically between these 
carcinogenic agents and the sex hormones is of extreme 




1 Because of recent warnings appearing in the litera-
ture against the therapeutic use of estrogenic sub-
stances and because of their similarity to carcino-
genic substances found in tar, this subject has been 
investigated. 
2 There is evidence that theelin is very similar chem-
ically to pure substances isolated from coal tar and 
known to be carcinogenic. 
3 Theelin, the follicular hormone, is responsible for 
proliferation of the ducts of the mammary gland, but 
requires the co~peration of progestin to produce al-
veolar proliferation. 
4 It has been found possible to decrease the incidence 
of mammary carcinoma in mice by prevention of breed-
ing or by surgical or X-ray castration. Breeding in-
creases the incidence. 
5 An opposite effect was found possible by the injec-
tion of theelin 
thus treated. 
tumors appeared even in males 
6 In the human, pregnancy or lactation increase mark-
edly the malignancy of breast cancer, and relative 
infertility or sterility is found to be associated 
with a higher incidence of breast cancers. 
7 O~phorectomy has been used in treating breast can-
cers in women not yet at the menopause. At present 
X-ray castration is widely used. 
8 Indications for X-ray castra.tion are : (1) breast 
cancer in a woman not yet at the menopause, (2) 
opera.ble or inoperable breast ca.ncer. 
9 Pregnancy is contraindicated by breast cancer, and 
if it occurs therapeutic abortion should be done, 
unless bony metastases are already present. 
5? 
10 Women with breast cancer or any pre-cancerous lesion 
should not receive therapeutic injections of theelin 
or any of its related preparations. 
ll There is no other contraindication to the use of 
theelin provided it is not given in massive doses 
nor over a prolonged period. 
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